The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
There is also the issue of price pressures from both public health systems and private insurers as the GLP-1 class continues to grow and more generic versions are introduced
These include direct effects on GLP-1R + cells within joints, the heart, kidney, liver, and immune cells 14 and indirect actions through weight reduction and blood glucose control, as well as through interorgan communication to dampen inflammation via activation of GLP-1R in subsets of central nervous system neurons 15 (Figure 1B)
This is not because people lack discipline, but rather because their biology fights hard to return to its old set point
"GLP-1 medications are truly a breakthrough in weight management, but they can also create significant nutrient gaps in things like vitamin B12, vitamin D, iron and calcium," says Matthew Taylor, Sr
Ethics declarations Competing interests E.M
.png)
